TY - JOUR
T1 - Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women
AU - Clendenen, Tess V
AU - Ge, Wenzhen
AU - Koenig, Karen L
AU - Afanasyeva, Yelena
AU - Agnoli, Claudia
AU - Bertone-Johnson, Elizabeth
AU - Brinton, Louise A
AU - Darvishian, Farbod
AU - Dorgan, Joanne F
AU - Eliassen, A Heather
AU - Falk, Roni T
AU - Hallmans, Göran
AU - Hankinson, Susan E
AU - Hoffman-Bolton, Judith
AU - Key, Timothy J
AU - Krogh, Vittorio
AU - Nichols, Hazel B
AU - Sandler, Dale P
AU - Schoemaker, Minouk J
AU - Sluss, Patrick M
AU - Sund, Malin
AU - Swerdlow, Anthony J
AU - Visvanathan, Kala
AU - Liu, Mengling
AU - Zeleniuch-Jacquotte, Anne
N1 - © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
PY - 2021/10/21
Y1 - 2021/10/21
N2 - CONTEXT: We previously reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies.OBJECTIVE: This study assessed whether risk factors for breast cancer are correlates of AMH concentration.METHODS: This cross-sectional study included 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49) from 10 cohort studies among the general population.RESULTS: Adjusting for age and cohort, AMH positively associated with age at menarche (P < 0.0001) and parity (P = 0.0008) and inversely associated with hysterectomy/partial oophorectomy (P = 0.0008). Compared with women of normal weight, AMH was lower (relative geometric mean difference 27%, P < 0.0001) among women who were obese. Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001). We observed higher AMH concentrations among women who had had a benign breast biopsy (15% higher, P = 0.03), a surrogate for benign breast disease, an association that has not been reported. In analyses stratified by age (<40 vs ≥40), associations of AMH with body mass index and OCs were similar in younger and older women, while associations with the other factors (menarche, parity, hysterectomy/partial oophorectomy, smoking, and benign breast biopsy) were limited to women ≥40 (P-interaction < 0.05).CONCLUSION: This is the largest study of AMH and breast cancer risk factors among women from the general population (not presenting with infertility), and it suggests that most associations are limited to women over 40, who are approaching menopause and whose AMH concentration is declining.
AB - CONTEXT: We previously reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies.OBJECTIVE: This study assessed whether risk factors for breast cancer are correlates of AMH concentration.METHODS: This cross-sectional study included 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49) from 10 cohort studies among the general population.RESULTS: Adjusting for age and cohort, AMH positively associated with age at menarche (P < 0.0001) and parity (P = 0.0008) and inversely associated with hysterectomy/partial oophorectomy (P = 0.0008). Compared with women of normal weight, AMH was lower (relative geometric mean difference 27%, P < 0.0001) among women who were obese. Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001). We observed higher AMH concentrations among women who had had a benign breast biopsy (15% higher, P = 0.03), a surrogate for benign breast disease, an association that has not been reported. In analyses stratified by age (<40 vs ≥40), associations of AMH with body mass index and OCs were similar in younger and older women, while associations with the other factors (menarche, parity, hysterectomy/partial oophorectomy, smoking, and benign breast biopsy) were limited to women ≥40 (P-interaction < 0.05).CONCLUSION: This is the largest study of AMH and breast cancer risk factors among women from the general population (not presenting with infertility), and it suggests that most associations are limited to women over 40, who are approaching menopause and whose AMH concentration is declining.
KW - Adult
KW - Aging/blood
KW - Anti-Mullerian Hormone/blood
KW - Biomarkers
KW - Body Mass Index
KW - Breast Diseases/blood
KW - Breast Neoplasms/blood
KW - Cohort Studies
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Middle Aged
KW - Ovarian Reserve
KW - Pregnancy
KW - Premenopause/blood
KW - Risk Factors
U2 - 10.1210/clinem/dgab461
DO - 10.1210/clinem/dgab461
M3 - Article
C2 - 34157104
SN - 0021-972X
VL - 106
SP - e4542-e4553
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 11
ER -